Clarke R - Search Results

1

Endocrine resistance in breast cancer--An overview and update.

Clarke R, Tyson JJ, Dixon JM. Clarke R, et al. Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):220-34. doi: 10.1016/j.mce.2015.09.035. Epub 2015 Oct 9. Mol Cell Endocrinol. 2015. PMID: 26455641 Free PMC article. Review.

2

Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factors.

Brünner N, Zugmaier G, Bano M, Ennis BW, Clarke R, Cullen KJ, Kern FG, Dickson RB, Lippman ME. Brünner N, et al. Among authors: clarke r. Cancer Cells. 1989 Nov;1(3):81-6. Cancer Cells. 1989. PMID: 2701652 Review.

3

The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer.

Clarke R, Brünner N, Thompson EW, Glanz P, Katz D, Dickson RB, Lippman ME. Clarke R, et al. J Endocrinol. 1989 Jul;122(1):331-40. doi: 10.1677/joe.0.1220331. J Endocrinol. 1989. PMID: 2769157

4

Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Clarke R, Thompson EW, Leonessa F, Lippman J, McGarvey M, Frandsen TL, Brünner N. Clarke R, et al. Breast Cancer Res Treat. 1993;24(3):227-39. doi: 10.1007/BF01833263. Breast Cancer Res Treat. 1993. PMID: 8435478 Review.

5

Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo.

James MR, Skaar TC, Lee RY, MacPherson A, Zwiebel JA, Ahluwalia BS, Ampy F, Clarke R. James MR, et al. Among authors: clarke r. Endocrinology. 2001 Apr;142(4):1497-505. doi: 10.1210/endo.142.4.8091. Endocrinology. 2001. PMID: 11250930

6

Molecular and pharmacological aspects of antiestrogen resistance.

Clarke R, Skaar TC, Bouker KB, Davis N, Lee YR, Welch JN, Leonessa F. Clarke R, et al. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):71-84. doi: 10.1016/s0960-0760(00)00193-x. J Steroid Biochem Mol Biol. 2001. PMID: 11384865 Review.

7

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY, Zhu Y, Skaar TC, Gomez B, O'Brien K, Wang Y, Hilakivi-Clarke LA. Clarke R, et al. Oncogene. 2003 Oct 20;22(47):7316-39. doi: 10.1038/sj.onc.1206937. Oncogene. 2003. PMID: 14576841 Review.

8

Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer.

Riggins RB, Bouton AH, Liu MC, Clarke R. Riggins RB, et al. Among authors: clarke r. Vitam Horm. 2005;71:201-37. doi: 10.1016/S0083-6729(05)71007-4. Vitam Horm. 2005. PMID: 16112269 Review.

9

Multidrug resistance/P-glycoprotein and breast cancer: review and meta-analysis.

Clarke R, Leonessa F, Trock B. Clarke R, et al. Semin Oncol. 2005 Dec;32(6 Suppl 7):S9-15. doi: 10.1053/j.seminoncol.2005.09.009. Semin Oncol. 2005. PMID: 16360717 Review.

10

Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.

Zhu Y, Wang A, Liu MC, Zwart A, Lee RY, Gallagher A, Wang Y, Miller WR, Dixon JM, Clarke R. Zhu Y, et al. Among authors: clarke r. Int J Oncol. 2006 Dec;29(6):1581-9. Int J Oncol. 2006. PMID: 17089000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,164 results

Search Page